20m 39 9m

Oh My Green tosses together $20m
18th October 2018
Callum Cyrus
Stanford-Start X Fund has put its weight behind Oh My Green's seed round, which also attracted a host of venture capital firms.
Garrison rallies for $30m
15th October 2018
Callum Cyrus
Cybersecurity technology developer Garrison has received $5m from IP Group after being backed by Touchstone in 2015 and 2017.
Glympse Bio engineers $22m series A
11th October 2018
Callum Cyrus
Glympse Bio, a medical diagnostic sensor spinout from MIT, has secured $22m in a series A round ahead of clinical trials targeting fatty liver disease and cancer.
Modis modulates $30m series A
2nd October 2018
Callum Cyrus
Partly based on Columbia University research, Modis is advancing treatments for rare diseases caused by dysfunction in cellular mitochondria.
Licious catches $25m
1st October 2018
Rob Lavine
UCLA co-led the online meat and fish merchant's series C round, which included Bertelsmann, Sistema Asia and Vertex Ventures.
IDx eyes $33m
28th September 2018
Callum Cyrus
University of Iowa's medical diagnostics spinout IDx has collected $33m from investors including Optum, bringing the company’s total to $48m.
Immune-Onc books $33m series B
21st September 2018
Callum Cyrus
Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.
Corelight spots $25m series B
13th September 2018
Callum Cyrus
UC Berkeley cybersecurity spinout Corelight has added General Catalyst to earlier investors including Accel Partners to bring its total funding to $34.2m.

Other News

AutoGrid charges $32m series D
13th September 2018
Robert Lavine
AutoGrid, the distributed energy management platform backed by Stanford, will use the capital from the Eon, CLP, Innogy, Total, Ørsted and Tenaska-backed round to boost hiring.
PhaseBio attracts $34m in series D round
7th September 2018
Robert Lavine
Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline, based on research from Duke University.
SkyRyse glides steady with $25m
3rd September 2018
Callum Cyrus
Air transit assistance system startup SkyRyse has accrued $25m in seed and series A funding from investors including Stanford University.
Genomics detects $32.5m series B
30th August 2018
Thierry Heles
Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.
Millendo overtakes OvaScience in merger deal
14th August 2018
Robert Lavine
Endocrine disease therapy developer Millendo, spun out of University of Michigan, will merge with publicly-listed OvaScience, raising a further $30m in the process.
Sarepta carries Lacerta through $30m round
14th August 2018
Callum Cyrus

Editor's Picks

Tel Aviv partners with Tata
29th April 2013
Gregg Bayes-Brown
Tel Aviv University announces $20m commercialisation fund with Tata Industries.
UK graphene research nets $35m backing
2nd January 2013
Gregg Bayes-Brown
Cell Medica raises $26.5m
25th July 2012
Toby Lewis
Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.
Revolymer sticks to AIM in IPO
16th July 2012
Toby Lewis
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
© 2018 Mawsonia Ltd. All rights reserved.
test reg

Login

Forgot password?

Not yet subscribed?

See your subscription offers here